live In the news:
Novo Nordisk New Pill Reduces Heart Attacks, Strokes in Diabetic Patients - The pill form of Novo Nordisk's drug Ozempic can cut the risk of heart attacks and strokes, according to a new study - Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says - Novo Nordisk CEO grilled over steep weight loss drug costs - Novo Nordisk's experimental weight loss pill has some concerning side effects - Novo Nordisk claims obesity drug effective for under-12s - A Novo Nordisk weight loss drug lowers BMI in kids as young as 6

Novo Nordisk

2 days ago
bookmarkAdd to library

Key facts

In classification: organization

Summary

The company Novo Nordisk is from Japan and operates in the Health Care sector.

Business

Novo Nordisk is one of the companies in Japan and one of the companies in Health Care. Novo Nordisk is one of the 3,466,499 companies in our database.
  • Employees: get premium Premium to see estimate
  • Revenues: get premium Premium to see estimate

Stocks from Novo Nordisk

Explore more on business

Talking Points:

  • ノボ ノルディスク ファーマ株式会社ホーム
  • ノボ ノルディスク
  • ノボ ノルディスク ファーマ株式会社公式アカウントです。弊社のさまざまなニュースや取り組みについてご紹介します。 弊社製品をお使いの患者様からの操作方法等に関するお問い合わせは弊社ウェブサイトをご参照ください。https://t.co/bNBVzRUHPxu3000利用規約はこちらからhttps://t.co/QT60CcxQFS
  • Driving change to defeat diabetes and other serious chronic diseases. Join us to learn more about our latest innovations | Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and ...
Learn more about talking points

In literature

There is no book written about Novo Nordisk in our database

Related

Connected or similar:

    Details

    This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter

    This content can be used under the CC BY 4.0 license